Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

PJ Online | (Meeting) Association of Independent Multiple pharmacies

Home > PJ (Current issue) > Meetings and Conferences | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7183 p144
2 February 2002

PDF* 50K

Meetings & Conferences

Association of Independent Multiple pharmacies

The Association of Independent Multiple Pharmacies (AIMp) has now had expressions of interest from owners representing around 900 pharmacies. It held its inaugural meeting in Leicester on 23 January. Sue Sharpe, chief executive of the Pharmaceutical Services Negotiating Committee, was the guest speaker

We can't go on with a flawed contract

Sue Sharpe with AIMp committee members David Vanns, Yakub Patel and Steve Williams (right to left)

The aims of AIMp

The Association of Independent Multiple Pharmacies has been formed because its members have similar businesses and thus similar interests, according to its chairman, Peter Cattee of the Peak Pharmacy group. He said that membership of AIMp, which is open to private companies owning between 10 and 200 pharmacy contracts in England and Wales, should be an aspiration for independent pharmacies. Further details are available from David Vanns on 01302 369121 (e-mail

The current community pharmacy contract is profoundly flawed and a whole new contract is needed, Sue Sharpe told the meeting. Community pharmacy in England has received a "diabolically bad" remuneration settlement from the Department of Health and, at the same time, a series of changes were threatening to take more money out of pharmacy businesses, affecting the totality of the service.

She outlined some of the major issues facing pharmacy:

Discount inquiry The Department of Health is proposing, and the PSNC resisting, a new discount inquiry

PCTs Primary care trusts will soon be taking over responsibility for pharmacy

Control of entry The Office of Fair Trading is investigating the pharmacy market and, in particular, the rules surrounding contract limitation and control of entry. "This review was not stimulated by the Department of Health (or at all welcomed by it)."

LPS Draft guidance on local pharmaceutical services has been issued but it does not make clear how LPS will be funded or how attractive or secure it will be in relation to the national contract. "It would be wrong to resist entirely the development of LPS, and how new roles can be developed and rewarded, but we see LPS as a way of meeting some local needs and not a wholesale migration from a national contract."

Medicines management The PSNC pilot studies are one way of achieving medicines management services. Other ways could include structured reviews or repeat dispensing

Prescribing Pharmacist and nurse prescribing is being introduced partially as a way of overcoming shortages of doctors, Mrs Sharpe said. "Community pharmacy needs to make sure that it is not left out of the picture. Full access to medical records is not necessary for supplementary prescribing. Most GPs do not look back through a full medical record before prescribing, and prescribing in hospitals takes place in isolation from any GP records. Access to relevant information is what is needed. We must not be excluded by overcomplicated and unnecessary criteria."

Clinical governance "The National Patient Safety Agency is potentially a great ally for community pharmacy. Picking up prescribing errors is one of our strengths."

New contract

"We need a whole new contract because the current structure is absolutely lousy," Mrs Sharpe said. The global sum is linked to increases in retail prices or to changes in National Health Service professional salary levels. That means that funding that is supposed to run a business is linked to political considerations and is not sensitive to volume increases or the costs of the non-NHS business. The impact of this over the past decade has been progressively negative.

"We have got a manpower shortage — even if this has not been acknowledged by some — and so costs have gone up."

Pharmacy needed to gather evidence on the costs of providing pharmaceutical services. It needed an agreed model to identify costs that allowed these to be linked to providing reasonable services in line with Government targets.

The PSNC's approach to renegotiating the pharmacy contract will be on the basis of allowing marginal but efficient independent community pharmacies to make a reasonable level of income.

"Any other model will end up rewarding the average pharmacy and, by definition, half of all pharmacies are below average. This simply will not do as a model for providing a valuable health care service.

PSNC representation

AIMp says that it wants to be represented on the PSNC. Mrs Sharpe said that the PSNC has to represent all pharmacy contractors properly and democratically. By her own calculations, regional multiples of the kind AIMp is recruiting, make up around 25 per cent of pharmacies in England with the larger nationals (over 200 pharmacies) making up around 35 per cent. The PSNC is currently looking at its constitution. Its current make up does not reflect the market as it now stands, Mrs Sharpe said.

"It needs a culture shift at the Department of Health. It cannot go on trying to cherry pick bits out of the total remuneration structure."

Asked how the cultural gap with the Department of Healthcould be closed, Mrs Sharpe said that pharmacy had to avoid being marginalised in a supply role. It had to become a source of reasonable, manageable solutions.

"We need to build in, and then phase in, quality structures to the new contract. We must address and incentivise skill mix changes and roll out manageable services that we can deliver."

One way in which this could be achieved was through a central contract that covered more than just dispensing. There were many chronic conditions, such as diabetes or asthma, that were seen in all areas of the country. There could be a central contract with a structured, costed menu of options that PCTs could take up and pay for via the global sum. LPS would then be additional services to meet specific local needs.

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20005925

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.